Primary sclerosing cholangitis (PSC)
Clinical trials for Primary sclerosing cholangitis (PSC) explained in plain language.
Never miss a new study
Get alerted when new Primary sclerosing cholangitis (PSC) trials appear
Sign up with your email to follow new studies for Primary sclerosing cholangitis (PSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for rare liver disease
Disease control CompletedThis study tested a drug called HTD1801 in 59 adults with primary sclerosing cholangitis (PSC), a rare liver disease. Participants took either a low dose, a high dose, or a placebo for 18 weeks. The main goal was to see if the drug could lower a liver enzyme called ALP, which is …
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Phase 2 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a common supplement ease a rare liver disease?
Disease control CompletedThis trial tests whether a dietary supplement called SAMe can improve liver health and quality of life in people with primary sclerosing cholangitis (PSC), a chronic liver disease. Participants will receive either SAMe or a placebo for a period, and researchers will measure chang…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a T-Cell signature unlock the secrets of autoimmune liver disease?
Knowledge-focused CompletedThis study aims to identify the unique molecular signature of immune cells called T cells that mistakenly attack the liver in autoimmune liver diseases like autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. Researchers will analyze blood sampl…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC